Search

Heparin-induced thrombocytopenia (HIT) is an uncommon problem in hemodialysis (HD) patients. There have been a few reports on the use of lepirudin, argatroban, or danaparoid in the management of extracorporeal thrombosis (ECT) during dialysis in these patients, because heparin is contraindicated. Here, we report the first long-term use of bivalirudin to prevent ECT. Our study was conducted at Fahd Bin Jassim Kidney Center in Doha, Qatar. All patients diagnosed with HIT were included. A bivalirudin treatment protocol was developed with the initial dosage and dosage adjustments based on the value of activated partial thromboplastin time (aPTT), the risk of bleeding, and the recurrence of ECT. Eight patients were positive for HIT AB. Among them, three were excluded: two due to the use of warfarin for atrial fibrillation and one due to a negative repeat HIT AB test with no ECT. Five patients who were positive for HIT AB and experienced recurrent ECT events during dialysis were included. These patients were monitored while on bivalirudin protocol for a mean of 4.6 ± 2 months, during which they received a mean number of HD treatments of 66 ± 24. There were no bleeding events or adverse reactions related to bivalirudin during the study. Here, we report the first long-term successful use of a bivalirudin protocol to prevent ECT in ambulatory HD patients with HIT. This protocol allowed for a simple dosing initiation with easy adjustment based on weight, aPTT, and recurrence of ECT events. The protocol provided excellent safety.

Background Older patients receiving home health care are particularly at risk of receiving potentially inappropriate medications compared to community-dwelling population. Data on appropriateness of prescribing in these patients is limited. Objective To investigate the prevalence, patterns and determinants of potentially inappropriate medications among elderly patients receiving Home Health Care Services in Qatar. Setting Home Health Care Services department in Hamad Medical Corporation-Qatar. Methods A cross-sectional study, conducted over a 3 months period. Patients 65 years and older, taking at least one medication and receiving home care services were included. Potentially inappropriate medications were identified and classified in accordance with the American Geriatrics Society 2012 Beers Criteria. Main outcome measure Prevalence of potentially inappropriate medications using updated Beers criteria. Results A total of 191 patients (38.2 %) had at least one potentially inappropriate medication. As per Beers criteria, 35 % of medications were classified as medications to be avoided in older adults regardless of conditions and 9 % as potentially inappropriate medications when used with certain diseases or syndromes. The majority of potentially inappropriate medications (56 %) were classified as medications to be used with caution. The two leading classes of potentially inappropriate medications were antipsychotics (27.4 %) and selective serotonin reuptake inhibitors (16 %). Significant predictors of inappropriate prescribing were hypertension [adjusted OR 1.7; 95 % CI (1.0, 2.8)], dementia [adjusted OR 2.0; 95 % CI (1.2, 3.1)], depression [adjusted OR 21.6; 95 % CI (2.8, 168.4)], and taking more than ten prescribed medications [adjusted OR 1.9; 95 % CI (1.3, 2.8)]. Conclusion Prescribing potentially inappropriate medications is common among older adults receiving home health care services in Qatar, a finding that warrants further attention. Polypharmacy, hypertension, depression and dementia were significantly associated with potentially inappropriate prescribing.